Overview
LTGO market data
Price History
LTGO price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- — Diluted earnings per share over the trailing twelve months.
- Beta
- — Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $17.22 – $22.47 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap —.
Company News
Trading Halt: Halt status updated at 9:50:00 AM ET: Quotation Resumption: IPO security released for quotationBenzinga · Aug 7, 2026, 1:50 PM
Reported Earlier, Latigo Biotherapeutics Prices Upsized $345.6M Initial Public Offering Of 19.2M Shares At $18.00 Per ShareBenzinga · Aug 7, 2026, 7:59 AM
Reported Earlier, Latigo Biotherapeutics Files To Sell Up To 16M IPO Shares Priced At $16-$18 Per ShareBenzinga · Aug 3, 2026, 12:19 PM